Letters, Testimony & Filings Letter to Congress Regarding Legislation to Reauthorize PDUFA and MDUFA April 25, 2022
Comments Submitted to the FDA Regarding Reauthorization of the Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027 (MDUFA V) April 21, 2022
Letters, Testimony & Filings Testimony at the FDA’s Public Meeting Regarding Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027 April 19, 2022
Press Releases White House’s Second Global COVID Summit Suffers From Late and Anemic Response as Pandemic Death Estimates Skyrocket April 18, 2022
Letters, Testimony & Filings Public Citizen Intervention at WHO Public Hearing on Pandemic Instrument April 12, 2022
Press Releases CMS Resists Big Pharma Pressure Campaign, Makes the Right Call in Restricting Medicare Coverage for the Alzheimer’s Disease Drug Aducanumab April 7, 2022